Suppliers News

Evonik Reports Weak Quarter in Q2 2025 Due to Declining Demand

In an increasingly difficult economic environment, Evonik’s adjusted EBITDA in 2Q 2025 declined by 12% to €509 million.

In an increasingly difficult economic environment, Evonik’s adjusted EBITDA in the second quarter of 2025 declined by 12% to €509 million compared to the robust results in the previous year (Q2 2024: €578 million). “Weak demand and high uncertainty characterized the second quarter,” says CEO Christian Kullmann. “That also shows in our numbers.” At €3.5 billion, quarterly revenue was 11% lower year-over-year (Q2 2024: €3.93 billion). More than half of this decline is...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters